How much funding has Tectonic Therapeutic raised?

Tectonic Therapeutic has raised $265.0M in total funding, most recently a Private Equity round.

Who are Tectonic Therapeutic's investors?

Tectonic Therapeutic's investors include Polaris Partners, Farallon Capital, Vida Ventures, T.A. Springer, 5AM Ventures, EcoR1 Capital.

When was Tectonic Therapeutic founded?

Tectonic Therapeutic was founded in 2020.

Where is Tectonic Therapeutic headquartered?

Tectonic Therapeutic is headquartered in Watertown, Massachusetts, United States.

What industry is Tectonic Therapeutic in?

Tectonic Therapeutic operates in Biotech, Healthcare.

How many employees does Tectonic Therapeutic have?

Tectonic Therapeutic has 51-200 employees.

Tectonic Therapeutic

IPO

Transforming the discovery of novel GPCR-targeted therapies

Public · Watertown, United States · Founded 2020 · $265.0M raised

Biotech

Healthcare

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2020
Business Model: B2B
Website: tectonictx.com

Total Funding: $265.0M
Last Round: $185.0M Private EquityFeb 2025
Rounds: 2
Type: Public

About

Tectonic is a clinical-stage biotech co-founded by Harvard Medical School scientists, developing therapeutic proteins and antibodies targeting G-Protein Coupled Receptors (GPCRs) using its proprietary GEODe™ platform. Its pipeline addresses significant unmet medical needs including Group 2 Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia.

Summary

Tectonic Therapeutic is a Biotech company based in Watertown, United States, founded in 2020. It has raised $265.0M in total across 2 rounds, most recently a $185.0M Private Equity round in Feb 2025. Investors include Polaris Partners, Farallon Capital and Vida Ventures.

LinkedIn X (Twitter)GitHub